N-acetylcysteine reduces oxidative stress on end-organs in an ischemia-reperfusion rat model
N-acetylcysteine reduces oxidative stress on end-organs in an ischemia-reperfusion rat model
Aim: In this study, we researched the effect of N-acetylcysteine (NAC) on parenchymal organs in ischemia-reperfusion injury in therat models.Material and Methods: Experimental animals divided into four groups: Sham group (Sh, n=6), Sham+NAC group (Sh+NAC, n=6),ischemia-reperfusion group (I/R, n=10) and N-acetylcysteine-given study group (I/R+NAC, n=10). For the Sham group and Sham +NAC group, only aortic exploration was performed. I/R group’s abdominal aortas were clamped just inferior to the renal artery for 4hours following. Then, the reperfusion period was allowed for one hour. I/R+NAC group received the same procedure as I/R groupand additionally treated with NAC intraperitoneally. After these procedures, all rats were sacrificed. The parenchymal organs wereexcised for biochemical, flow cytometric and histopathologic examination. The data were evaluated statistically.Results: In the I/R+NAC group, the MDA values in AC tissue were significantly lower than the I/R group (p:0.0032). MDA value inkidney tissue was significantly higher in the I/R group compared to the control groups (p:0.003). In the I/R+NAC group, the MDA valuewas significantly lower than the I / R group (p:0.0002). MPO values in lung tissue were found lower in the I/R+NAC group comparedto the I/R group, it was not statistically significant (p:0.4497). In the I/R+NAC group, it was found statistically significantly lowerthan both the control and I/R groups in Flow cytometric evaluation (p:0.0002). In histopathological evaluation, the leukocyte countobserved significantly higher in the I/R+NAC group compared to the control groups and was statistically significantly lower than theI/R group in histopathological evaluation (p:0,0004).Conclusion: NAC reduces ischemia and reperfusion injury in parenchymal organs and especially in the lungs in a rat model
___
- 1. Takhtfooladi HA, Hesaraki S, Razmara F, et al. Effects of N-acetylcysteine and pentoxifylline on remote lung injury in a rat model of hind-limb ischemia/reperfusion injury. J Bras Pneumol 2016;42:9-14.
- 2. Li C, Jackson RM. Reactive species mechanisms of cellular hypoxiareoxygenation injury. Am J Physiol Cell Physiol 2002;282:227-41.
- 3. Tangül SU, Çakmak AM, Çağlayan O, et al. Prevention of the harmful effects of free oxygen radicals by using N-acetylcysteine in testicular torsion. J Pediatr Urol 2019:30371-7.
- 4. Seifi B, Kadkhodaee M, Delavari F, et al. Pretreatment with pentoxifylline and N-acetylcysteine in liver ischemia reperfusion-induced renal injury. Ren Fail.2012;34:610-5
- 5. Guo DW, Wang CY, Shih HC. N-acetylcysteine and atorvastatin alleviates lung injury due to ischemiareperfusion injury in rats.J Chin Med Assoc 2019 ;82:909-14.
- 6. Forgiarini LF, Forgiarini LA Jr, da Rosa DP, et al. N-acetylcysteine administration confers lung protection in different phases of lung ischaemiareperfusion injury. Interact Cardiovasc Thorac Surg 2014;19:894-9.
- 7. Uysal AI, Ocmen E, Akan M, et al. The effects of remote ischemic preconditioning and N-acetylcysteine with remote ischemic preconditioning in rat hepatic ischemia reperfusion injury model. Biomed Res Int 2014;2014:892704.
- 8. Cerqueira NF, Hussni CA, Yoshida WB, et al. Effects of pentoxifylline and n-acetylcysteine on injuries caused by ischemia and reperfusion of splanchnic organs in rats. Int Angiol 2008;27:512-21.
- 9. Bartekova M, Barancik M, Ferenczyova K, et al. Beneficial Effects of N-acetylcysteine and N-mercaptopropionylglycine on Ischemia Reperfusion Injury in the Heart. Curr Med Chem 2018;25:355-66.
- 10. Wang T, Qiao S, Lei S, et al. N-acetylcysteine and allopurinol synergistically enhance cardiac adiponectin content and reduce myocardial reperfusion injury in diabetic rats. PLoS One 2011;6:23967.
- 11. Umaroglu Ozturk S, Tireli E, Yılmazbayhan D, et al. The effect of L-carnitine on cardiac injury in an experimental aortic ischemia-reperfusion injury model. Turkish J Vascular Surgery 2018;27:142-9.
- 12. van der Laan L, Oyen WJ, Verhofstad AA, et al. Soft tissue repair capacity after oxygen-derived free radical-induced damage in one hindlimb of the rat. J Surg Res 1997;72:60-9.
- 13. Sen H, Deniz S, Yedekci AE, et al. Effects of dexpanthenol and N-acetylcysteine pretreatment in rats before renal ischemia/reperfusion injury. Ren Fail 2014;36:1570-4.
- 14. Seifi B, Kadkhodaee M, Delavari F, et al. Pretreatment with pentoxifylline and N-acetylcysteine in liver ischemia reperfusion-induced renal injury. Ren Fail 2012;34:610-5.
- 15. Cusumano G, Romagnoli J, Liuzzo G, et al. N-Acetylcysteine and High-Dose Atorvastatin Reduce Oxidative Stress in an Ischemia-Reperfusion Model in the Rat Kidney. Transplant Proc 2015;47:2757-62.
- 16. Ege T, Eskiocak S, Edis M, et al. The role of N-acetylcysteine in lower extremity ischemia/ reperfusions.J Cardiovasc Surg (Torino) 2006 ;47:563- 8.
- 17. Koksal C, Bozkurt AK, Ustundag N, et al. Attenuation of acute lung injury following lower limb ischemia/ reperfusion: the pharmacological approach. J Cardiovasc Surg (Torino) 2006;47:445-9.
- 18. Koksal C, Bozkurt AK, Cangel U, et al. Attenuation of ischemia/reperfusion injury by N-acetylcysteine in a rat hind limb model. J Surg Res. 2003;111:236-9.
- 19. Tassiopoulos AK, Carlin RE, Gao Y, et al. Role of nitric oxide and tumor necrosis factor on lung injury caused by ischemia/reperfusion of the lower extremities. J Vasc Surg 1997;26:647-56.
- 20. Klausner JM, Paterson IS, Kobzik L, et al. Vasodilating prostaglandins attenuate ischemic renal injury only if thromboxane is inhibited. Ann Surg 1989;209:219-24.
- 21. Buege TA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302-10.
- 22. Schierwagen C, Bylund-Fellenius AC, Lundberg C. Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. J Pharmacol Methods 1990;23:179-86.
- 23. Sochman J. N-acetylcysteine in acute cardiology: 10 years later: what do we know and what would we like to know?! J Am Coll Cardiol 2002;39:1422-8.